Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
17,796,004
-
Share change
-
-1,641,479
-
Total reported value
-
$7,849,000
-
Price per share
-
$0.44
-
Number of holders
-
42
-
Value change
-
-$1,437,442
-
Number of buys
-
19
-
Number of sells
-
15
Institutional Holders of THRESHOLD PHARMACEUTICAL INC - COM NEW (THLD) as of Q4 2016
As of 31 Dec 2016,
THRESHOLD PHARMACEUTICAL INC - COM NEW (THLD) was held by
42 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
17,796,004 shares.
The largest 10 holders included
First Eagle Investment Management, LLC, DEERFIELD MANAGEMENT CO, VANGUARD GROUP INC, BlackRock Institutional Trust Company, N.A., Cormorant Asset Management, LLC, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, FMR LLC, JACOBS LEVY EQUITY MANAGEMENT, INC, and Rhenman & Partners Asset Management AB.
This page lists
42
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.